Coronary artery endothelial cells and microparticles increase expression of VCAM-1 in myocardial infarction

Coronary artery disease (CAD) is characterised by progressive atherosclerotic plaque leading to flow-limiting stenosis, while myocardial infarction (MI) occurs due to plaque rupture or erosion with abrupt coronary artery occlusion. Multiple inflammatory pathways influence plaque stability, but direct assessment of endothelial inflammation at the site of coronary artery stenosis has largely been limited to pathology samples or animal models of atherosclerosis. We describe a technique for isolating and characterising endothelial cells (ECs) and EC microparticles (EMPs) derived directly from the site of coronary artery plaque during balloon angioplasty and percutaneous coronary intervention. Coronary artery endothelial cells (CAECs) were identified using imaging flow cytometry (IFC), and individual CAEC and EMP expression of the pro-atherogenic adhesion molecule vascular cell adhesion molecule-1 (VCAM-1) was assessed immediately following angioplasty. Patients with MI registered 73 % higher VCAM-1 expression on their CAECs and 79 % higher expression on EMPs compared to patients with stable CAD. In contrast, VCAM-1 expression was absent on ECs in the peripheral circulation from these same subjects. VCAM-1 density was significantly higher on CAECs and EMPs among patients with MI and positively correlated with markers of myocardial infarct size. We conclude that increased VCAM-1 expression on EC and formation of EMP at the site of coronary plaque is positively correlated with the extent of vascular inflammation in patients with myocardial infarction.

[1]  Michael F. Oliver,et al.  Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study. , 2001, Indian heart journal.

[2]  S. Simon,et al.  Triglyceride-Rich Lipoproteins Prime Aortic Endothelium for an Enhanced Inflammatory Response to Tumor Necrosis Factor-α , 2007, Circulation research.

[3]  G. Lip,et al.  Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor. , 2004, European heart journal.

[4]  G. Lip,et al.  Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis , 2010, Journal of thrombosis and haemostasis : JTH.

[5]  M. Harmsen,et al.  Uninfected and cytomegalic endothelial cells in blood during cytomegalovirus infection: effect of acute rejection. , 2000, The Journal of infectious diseases.

[6]  A. Karsan,et al.  Apoptotic vascular endothelial cells become procoagulant. , 1997, Blood.

[7]  A. Gascoigne,et al.  Circulating endothelial cells in patients with septic shock. , 2001, American journal of respiratory and critical care medicine.

[8]  S. Alper,et al.  Hemodynamic shear stress and its role in atherosclerosis. , 1999, JAMA.

[9]  A. Le Bivic,et al.  Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. , 2001, Blood.

[10]  C M Gibson,et al.  Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. , 2000, Circulation.

[11]  E. Wayner,et al.  Circulating activated endothelial cells in sickle cell anemia. , 1997, The New England journal of medicine.

[12]  J. Lehmann,et al.  MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Khera,et al.  Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association , 2011, Circulation.

[14]  E. Braunwald,et al.  TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.

[15]  F. Ingegnoli,et al.  Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. , 2004, Arthritis and rheumatism.

[16]  Wade T Rogers,et al.  Endothelial microparticles: Sophisticated vesicles modulating vascular function , 2013, Vascular medicine.

[17]  Françoise Dignat-George,et al.  Circulating endothelial cells , 2005, Thrombosis and Haemostasis.

[18]  Lan Huang,et al.  Isolation and Characterization of Human Coronary Artery-Derived Endothelial Cells in vivo from Patients Undergoing Percutaneous Coronary Interventions , 2009, Journal of Vascular Research.

[19]  T. George,et al.  Flow cytometric analysis of microparticles. , 2011, Methods in molecular biology.

[20]  Suades Soler,et al.  Role of microparticles in atherothrombosis , 2014 .

[21]  G. Lip,et al.  Circulating endothelial cells in cardiovascular disease. , 2006, Journal of the American College of Cardiology.

[22]  P. Ganz,et al.  Role of endothelial dysfunction in coronary artery disease and implications for therapy. , 1997, The American journal of cardiology.

[23]  P. Ganz,et al.  Role of Endothelial Dysfunction in Atherosclerosis , 2004, Circulation.

[24]  M. Cybulsky,et al.  Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. , 1999, Circulation research.

[25]  G. Lip,et al.  Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. , 2005, Blood.

[26]  P. Libby,et al.  Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. , 1993, The American journal of pathology.

[27]  A. Blann,et al.  HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Direct Evidence of Endothelial Injury in Acute Myocardial Infarction and Unstable Angina by Demonstration of Circulating Endothelial Cells , 1999 .

[28]  R. Nieuwland,et al.  Cellular microparticles: new players in the field of vascular disease? , 2004, European journal of clinical investigation.

[29]  D. Stern,et al.  Human endothelium: endovascular biopsy and molecular analysis. , 1999, Radiology.

[30]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[31]  J. Freyssinet,et al.  Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation. , 2009, Atherosclerosis.

[32]  D. Ingram,et al.  Identification of Endothelial Cells and Progenitor Cell Subsets in Human Peripheral Blood , 2010, Current protocols in cytometry.

[33]  S. Sleijfer,et al.  A new approach for rapid and reliable enumeration of circulating endothelial cells in patients , 2012, Journal of thrombosis and haemostasis : JTH.

[34]  S. Blankenberg,et al.  Circulating Cell Adhesion Molecules and Death in Patients With Coronary Artery Disease , 2001, Circulation.

[35]  M. Gimbrone,et al.  Vascular endothelium responds to fluid shear stress gradients. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[36]  M. Yoder,et al.  Flow Cytometric Identification and Functional Characterization of Immature and Mature Circulating Endothelial Cells , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[37]  J. Heymach,et al.  Validation of a Standardized Method for Enumerating Circulating Endothelial Cells and Progenitors: Flow Cytometry and Molecular and Ultrastructural Analyses , 2009, Clinical Cancer Research.

[38]  Sung-Yu Hong,et al.  Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction. , 2013, Atherosclerosis.

[39]  C. Vassanelli,et al.  [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[40]  P. Libby,et al.  Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis. , 1993, The Journal of clinical investigation.

[41]  G. Grau,et al.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. , 1999, The Journal of clinical investigation.

[42]  A. Kastrati,et al.  Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction , 2004, Thrombosis and Haemostasis.

[43]  J Philip McCoy,et al.  Imaging flow cytometry for morphologic and phenotypic characterization of rare circulating endothelial cells , 2013, Cytometry. Part B, Clinical cytometry.

[44]  P. Libby,et al.  Inflammatory Biomarkers, Death, and Recurrent Nonfatal Coronary Events After an Acute Coronary Syndrome in the MIRACL Study , 2013, Journal of the American Heart Association.

[45]  S. Sleijfer,et al.  Cells meeting our immunophenotypic criteria of endothelial cells are large platelets , 2007, Cytometry. Part B, Clinical cytometry.

[46]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[47]  Amir Lerman,et al.  Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[48]  A. M. Leone,et al.  Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention. , 2012, European heart journal.